1. Home
  2. BCYC vs ISD Comparison

BCYC vs ISD Comparison

Compare BCYC & ISD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • ISD
  • Stock Information
  • Founded
  • BCYC 2009
  • ISD 2012
  • Country
  • BCYC United Kingdom
  • ISD United States
  • Employees
  • BCYC N/A
  • ISD N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • ISD Trusts Except Educational Religious and Charitable
  • Sector
  • BCYC Health Care
  • ISD Finance
  • Exchange
  • BCYC Nasdaq
  • ISD Nasdaq
  • Market Cap
  • BCYC 566.5M
  • ISD 472.3M
  • IPO Year
  • BCYC 2019
  • ISD N/A
  • Fundamental
  • Price
  • BCYC $8.70
  • ISD $14.19
  • Analyst Decision
  • BCYC Buy
  • ISD
  • Analyst Count
  • BCYC 11
  • ISD 0
  • Target Price
  • BCYC $25.00
  • ISD N/A
  • AVG Volume (30 Days)
  • BCYC 308.3K
  • ISD 127.1K
  • Earning Date
  • BCYC 08-05-2025
  • ISD 01-01-0001
  • Dividend Yield
  • BCYC N/A
  • ISD 9.69%
  • EPS Growth
  • BCYC N/A
  • ISD N/A
  • EPS
  • BCYC N/A
  • ISD N/A
  • Revenue
  • BCYC $25,722,000.00
  • ISD N/A
  • Revenue This Year
  • BCYC $7.35
  • ISD N/A
  • Revenue Next Year
  • BCYC N/A
  • ISD N/A
  • P/E Ratio
  • BCYC N/A
  • ISD N/A
  • Revenue Growth
  • BCYC N/A
  • ISD N/A
  • 52 Week Low
  • BCYC $6.10
  • ISD $10.98
  • 52 Week High
  • BCYC $28.67
  • ISD $13.17
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 61.54
  • ISD 59.49
  • Support Level
  • BCYC $8.21
  • ISD $14.01
  • Resistance Level
  • BCYC $9.18
  • ISD $14.14
  • Average True Range (ATR)
  • BCYC 0.50
  • ISD 0.10
  • MACD
  • BCYC 0.12
  • ISD -0.02
  • Stochastic Oscillator
  • BCYC 76.81
  • ISD 63.33

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About ISD PGIM High Yield Bond Fund Inc.

PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The Fund's investment objective is to provide a high level of current income. It invests at least 80% of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.

Share on Social Networks: